Stability of alginate microbead properties in vitro

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 4, 2012, Pages 903-912

  Moya, Monica L ^a,b   Morley, Michael ^a,b   Khanna, Omaditya ^b   Opara, Emmanuel C ^c   Brey, Eric M ^a,b,d  

^a ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

^b Illinois Institute of Technology   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID CONTENT; BIOLOGICAL RESPONSE; CELL BEHAVIORS; CELL DELIVERY; CELL THERAPY; CLINICAL APPLICATION; CULTURE MEDIUM; GULURONIC ACID; IN-VITRO; IN-VIVO; ISCHEMIC TISSUES; MANNURONIC ACIDS; MICROBEADS; MICROENVIRONMENTS; MORPHOMETRY; PHYSICAL CHARACTERISTICS; PROTEIN RELEASE; RAPID CHANGES; SOLUTE DIFFUSION; SYNTHESIS CONDITIONS; TEMPORAL VARIATION; THERAPEUTIC INTERVENTION; TISSUE REGENERATION; TYPE I DIABETES;

CALCIUM; CELL CULTURE; DRUG DELIVERY; NEEDLES; PHYSICAL PROPERTIES; TISSUE;

ALGINATE;

ALGINIC ACID; CALCIUM; MANNURONIC ACID; NANOBEAD;

ARTICLE; CONCENTRATION (PARAMETERS); IN VITRO STUDY; MICROENVIRONMENT; MORPHOMETRICS; PARTICLE SIZE; PRIORITY JOURNAL; SYNTHESIS;

ALGINATES; BIOCOMPATIBLE MATERIALS; GLUCURONIC ACID; HEXURONIC ACIDS; PROTEINS;

EID: 84863301555     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4575-9     Document Type: Article

References (32)

1. Opara EC, Mirmalek-Sani SH, Khanna O, Moya ML, Brey EM. Design of a bioartificial pancreas(?). J Investig Med. 2010; 58(7):831-7. doi:10.231/JIM.0b013e3181ed3807.
2. Garfinkel, Harland RC, Opara EC. Optimization of the microencapsulated islet for transplantation. J Surg Res. 1998;76(1): 7-10. doi:10.1006/jsre.1997. 5258. (Pubitemid 28363845)
3. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials. 1999;20(1): 45-53. doi:10.1016/S0142-9612(98)00107-0. (Pubitemid 29002544)
4. Khanna O, Moya ML, Opara EC, Brey EM. Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor-1. J Biomed Mater Res A. 2010;95(2): 632-40. doi:10.1002/jbm.a.32883.
5. Khanna O, Moya ML, Greisler HP, Opara EC, Brey EM. Multilayered microcapsules for the sustained-release of angiogenic proteins from encapsulated cells. Am J Surg. 2010;200(5):655-8. doi:10.1016/j.amjsurg.2010.08.001.
6. Moya ML, Garfinkel, Liu X, Lucas S, Opara EC, Greisler HP, Brey EM. Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization. J Surg Res. 2010;160(2):208-12. doi:10.1016/j.jss.2009.06. 003.
7. Maguire TJ, Novik EI, Schloss R, Yarmush ML Alginate encapsulation and hepatic differentiation of embryonic stem cells. In: Bioengineering conference, 2005. Proceedings of the IEEE 31st Annual Northeast, 2-3 April 2005. pp 213-214.
8. Moya ML, Cheng MH, Huang JJ, Francis-Sedlak ME, Kao SW, Opara EC, Brey EM. The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering. Biomaterials. 2010;31(10):2816-26. doi:10.1016/j.biomaterials.2009.12.053.
9. Moya ML, Lucas S, Francis-Sedlak M, Liu X, Garfinkel, Huang JJ, Cheng MH, Opara EC, Brey EM. Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration. Microvasc Res. 2009;78(2):142-7. doi:10.1016/j.mvr.2009.06.006.
10. Hoffman AS.Hydrogels for biomedical applications.Adv Drug Deliv Rev. 2002;54(1):3-12. doi:10.1016/S0169-409X(01)00239-3. (Pubitemid 34081178)
11. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev. 2001;101(7):1869-79. doi:10.1055/s-2007-973087. (Pubitemid 35377789)
12. Amsden B. Solute diffusion in hydrogels.: an examination of the retardation effect. Polym Gels Netw. 1998;6(1):13-43. doi: 10.1016/S0966- 7822(97)00012-9. (Pubitemid 128449863)
13. Goosen MFA. Physico-chemical and mass transfer considerations in microencapsulation. Ann NY Acad Sci. 1999;875(1):84-104. doi:10.1111/j.1749- 6632.1999.tb08496.x. (Pubitemid 29349064)
14. Uludag H, De Vos P, Tresco PA. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev. 2000;42(1-2):29-64. doi: 10.1016/S0169- 409X(00)00053-3. (Pubitemid 30609634)
15. Wee S, Gombotz WR. Protein release from alginate matrices. Adv Drug Deliv Rev. 1998;31(3):267-85. doi:10.1016/S0169-409X(97)00124-5. (Pubitemid 28191869)
16. Ruel M, Laham RJ, Parker JA, Post MJ, Ware JA, Simons M, Sellke FW. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg. 2002;124(1):28-34. doi:10.1067/mtc.2002. 121974.
17. Sellke FW, Laham RJ, Edelman ER, Pearlman JD, Simons M. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg. 1998;65(6): 1540-4. doi:10.1016/S0003-4975(98)00340-3. (Pubitemid 28313604)
18. Khurana R, Simons M. Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease. Trends Cardiovasc Med. 2003;13(3):116-22. doi:10.1016/S1050-1738(02)00259-1. (Pubitemid 36411807)
19. Vacanti CA, Bonassar LJ, Vacanti MP, Shufflebarger J. Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med. 2001;344(20):1511-4. doi:10.1056/NEJM200105 173442004. (Pubitemid 32429210)
20. Cook WH, Smith DB. Molecular weight and hydrodynamic properties of sodium alginate. Can J Biochem Physiol. 1954;32(3): 227-39.
21. Amsden B. Solute diffusion within hydrogels. Mechanisms and models. Macromolecules. 1998;31(23):8382-95. doi:10.1021/ma 980765f. (Pubitemid 128563527)
22. Hobbs HA, Kendall WFJ, Darrabie M, Opara EC. Prevention of morphological changes in alginate microcapsules for islet xenotransplantation. J Investig Med. 2001;49(6):572-5. doi:10.2310/6650.2001.33722. (Pubitemid 33104593)
23. Martinsen A, Skjåk-Bræk G, Smidsrød O. Alginate as immobilization material: i. correlation between chemical and physical properties of alginate gel beads. Biotechnol Bioeng. 1989;33(1): 79-89. doi:10.1002/bit.260330111. (Pubitemid 19010127)
24. Bajpai SK, Sharma S. Investigation of swelling/degradation behaviour of alginate beads crosslinked with Ca2+ and Ba2+ions. React Funct Polym. 2004;59(2):129-40. doi:10.1016/j. reactfunctpolym.2004.01.002.
25. Amsden B, Turner N. Diffusion characteristics of calcium alginate gels. Biotechnol Bioeng. 1999;65(5):605-10. doi:10.1002/(SICI) 1097-0290(19991205)65: 5\605:AID-BIT14[3.0.CO;2-C[pii]. (Pubitemid 29513653)
26. Darrabie MD, Kendall WF, Opara EC. Effect of alginate composition and gelling cation on microbead swelling. J Microencapsul. 2006;23(6):613-21. doi:10.1080/02652040600687621. (Pubitemid 44803854)
27. Klokk TI, Melvik JE. Controlling the size of alginate gel beads by use of a high electrostatic potential. J Microencapsul. 2002; 19(4):415-24. doi:10.1080/02652040210144234.
28. Yamagiwa K, Kozawa T, Ohkawa A. Effects of alginate composition and gelling conditions on diffusional and mechanical properties of calcium-alginate gel beads. J. Chem. Eng. 1995;28: 462-7. doi:10.1252/jcej.28.462.
29. Kendall WF, Jr, Darrabie MD, El-Shewy HM, Opara EC. Effect of alginate composition and purity on alginate microspheres. J Microencapsul. 2004;21(8):821-8. doi:10.1080/026520404000 15452. (Pubitemid 40109547)
30. Gu F, Amsden B, Neufeld R. Sustained delivery of vascular endothelial growth factor with alginate beads. J Control Release. 2004;96(3):463-72. doi:10.1016/j.jconrel.2004.02.021S0168365 904000999[pii]. (Pubitemid 38553924)
31. Edelman ER, Mathiowitz E, Langer R, Klagsbrun M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials. 1991;12(7):619-26. doi:10.1016/0142-9612(91)90107-L.
32. Dowd CJ, Cooney CL, Nugent MA. Heparan Sulfate Mediates bFGF Transport through Basement Membrane by Diffusion with Rapid Reversible Binding. J. Biol. Chem. 1999;274:5236-5244. doi:10.1074/jbc.274.8.5236. (Pubitemid 29113434)